In a burn patient, when should albumin be initiated, does the type of burn (e.g., superficial chemical burns covering more than 20% total body surface area) affect the timing, and what alternative colloids can be used instead of albumin?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 18, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Albumin Administration in Burn Patients

When to Start Albumin

For severe burn patients with >30% TBSA, albumin should be initiated after the first 6 hours of management, with optimal timing between 8-12 hours post-burn. 1 The evidence strongly supports delaying albumin administration beyond the initial resuscitation period, as immediate use does not prevent burn wound edema formation but can reduce non-burn tissue edema and preserve intravascular volume when given after capillary permeability begins to stabilize.

Timing Algorithm Based on Burn Severity:

  • TBSA >50%: Start albumin at 6-8 hours post-burn 2
  • TBSA 30-50%: Start albumin at 8-12 hours post-burn 1, 2
  • TBSA 20-30%: Start albumin at 12 hours post-burn if crystalloid requirements exceed 6 mL/kg/% TBSA at the 12-hour mark 3
  • TBSA <20%: Albumin generally not indicated 2

Target serum albumin level: >30 g/L with typical dosing of 1-2 g/kg/day (5% albumin solution). 1

Does Burn Type Affect Timing?

The available guidelines do not differentiate albumin timing based on burn mechanism (thermal vs. chemical vs. electrical). The primary determinant for albumin administration is TBSA percentage and depth, not the causative agent. 1

For Superficial Chemical Burns >20% TBSA:

Albumin is NOT recommended for superficial burns regardless of surface area. 2 The guidelines consistently emphasize that albumin indication is based on:

  • Burn depth (deep/full-thickness burns)
  • TBSA percentage (generally >20-30%)
  • Severity of capillary leak and fluid requirements

Superficial burns do not produce the same degree of capillary permeability and protein loss as deep burns, making albumin supplementation unnecessary and potentially harmful due to volume overload risk.

Critical Caveat:

If a "superficial chemical burn" is misclassified and actually involves deeper tissue injury (common with certain chemical agents like hydrofluoric acid or alkali burns), then standard burn resuscitation protocols including albumin would apply based on the true depth and TBSA.

Alternative Colloids to Albumin

Human albumin is the ONLY recommended colloid for burn resuscitation. 1

Explicitly Contraindicated:

  • Hydroxyethyl starches (HES): Absolutely contraindicated by the European Medicines Agency (EMA) and National Agency for Drug Safety (ANSM) in severe burns 1

Not Recommended:

  • Fresh frozen plasma (FFP): Insufficient evidence to recommend 4
  • Other synthetic colloids: No evidence supporting their use and potential for harm

The 2020 burn management guidelines explicitly state that human albumin is used by >60% of burn centers that employ colloids, and it remains the only colloid with supporting evidence for safety and potential efficacy in this population 1.

Practical Implementation

Indications to Start Albumin:

  1. Projected fluid requirements at 12 hours suggest total 24-hour volume will exceed 6 mL/kg/% TBSA 3
  2. Progressive fluid creep despite crystalloid titration 5
  3. Serum albumin <30 g/L with ongoing resuscitation needs 1
  4. Development of complications: abdominal compartment syndrome risk, excessive edema 1

Benefits of Albumin Use:

  • Reduces total crystalloid volume requirements 1, 5, 3
  • Decreases fluid input-to-output ratio 5
  • Reduces abdominal compartment syndrome incidence (15.4% to 2.8%) 1
  • May reduce mortality when high-risk studies are excluded (OR 0.34) 1
  • Shorter hospital length of stay 1, 6
  • Reduced mechanical ventilation duration 3

Pediatric Considerations:

In children with TBSA >15%, albumin should be started at 8-12 hours post-burn (earlier than adults) to prevent fluid creep and reduce crystalloid volumes. 1, 6 Pediatric patients have higher surface area-to-volume ratios and are at greater risk for over-resuscitation complications.

Important Warnings:

  • Do NOT use albumin in the first 6 hours: It cannot prevent burn wound edema and may worsen outcomes 1
  • Monitor for pulmonary edema: Albumin can increase extravascular lung water, particularly in the first post-burn week 7
  • Avoid in dehydrated patients: Use 5% albumin or additional crystalloids; 25% albumin is hyperoncotic and can worsen dehydration 8
  • Rate of administration: Should not exceed 2 mL/min in hypoproteinemic patients to avoid circulatory overload 8

Human albumin remains the standard colloid for burn resuscitation when indicated, with no acceptable alternatives currently supported by evidence.

References

Guideline

management of severe thermal burns in the acute phase in adults and children.

Anaesthesia Critical Care & Pain Medicine, 2020

Research

Early albumin use improves mortality in difficult to resuscitate burn patients.

The journal of trauma and acute care surgery, 2012

Research

American Burn Association Clinical Practice Guidelines on Burn Shock Resuscitation.

Journal of burn care & research : official publication of the American Burn Association, 2024

Research

The Impact of Albumin in Pediatric Burn Resuscitation.

Journal of burn care & research : official publication of the American Burn Association, 2026

Research

A review of the use of human albumin in burn patients.

Journal of burn care & research : official publication of the American Burn Association, 2012

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.